直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

醫療器材和診斷

About

醫療器材和診斷 業務的一部分 生命科學.

利用創新改善醫療保健和患者的日常生活

Finnegan與各種規模的創新客戶合作,包括財富100強,全球1000強,以及醫療設備和診斷產業的新創公司。拯救生命,提高病患生活品質,改善醫療保健服務,以及找出侵入性較小的疾病治療方法,是醫療器材產業的首要考量。高度競爭的診斷產業不斷尋求更快,更精準的檢測改良方法,以及研發新方法,以偵測不斷演變的標靶。創新者面臨許多挑戰,包括高度複雜的專利訴訟,利潤緊縮,產品生命週期變短,可能影響產品可行性的補償計劃,以及通常需要經歷漫長臨床試驗的昂貴研發之路。此外,新的器材必須符合美國食品藥品監督管理局的安全和行銷法規,該法規可能要求器材上市之前需公開揭露敏感的設計資訊。為保有競爭力,公司必須保護和執行其所擁有的智財權。

了解法律,科學,和技術

在Finnegan,我們擁有法律經驗和技術專長,可以幫助客戶解決在開發,保護,與商業化醫療器材和診斷發明中出現的許多問題。我們的經驗包括與大公司的內部律師合作,處理申請案,盡職調查,授權,和高風險的訴訟,到為新創公司的管理高層就營運決策提供建議,以幫助公司起步。我們了解醫療器材產業的高度競爭性,投資人和股東創造價值的需求,與智財權及早和強化保護的重要性。我們亦針對保護診斷發明之複雜且不斷變化的專利法規,提供客戶導航之協助。

從確定新產品的競爭環境到擬訂訴訟的制勝策略,我們協助的項目有:

  • 在地院和上訴法院,由經驗豐富的審判和上訴團隊,處理高價值產品的訴訟案
  • 制訂和執行申請策略,以保護客戶的產品,以及分析競爭對手的產品,從而確保 客戶理解其智財資產的價值
  • 提供法律意見並實際參與領證後的複審程序,包括多方複審和核准後複審         
  • 授權及其它商業化智財權交易的準備與談判
  • 減少專利障礙之研發方案的諮詢
  • 對併購的目標公司做盡職調查
  • 提供商標申請和諮詢服務

我們與醫療器材客戶合作,內容涉及廣泛的學科和技術,包括:

  • 糖尿病和血糖的自我檢測
  • 數位訊號處理
  • 藥物輸送系統
  • 藥物釋放型心臟支架
  • 電子醫療器材
  • 內視鏡和泌尿/婦科系統
  • 心臟介入手術器材
  • 醫療用品
  • 監控設備
  • 骨科
  • 手術器材
  • 治療儀器

我們與診斷產業客戶合作,亦橫跨廣泛的學科與技術,包括:

  • 基因篩選
  • 免疫篩選
  • 使用光譜法篩選
  • 使用人工智慧進行篩選
  • 癌症診斷
  • 微生物診斷
  • 產前診斷

保護創新之全面的法律,技術,和策略經驗

我們的生命科學業務由250多位律師和專業人士組成,致力於滿足客戶對於智財權服務的需求。多數擁有與生物學,化學,生物化學,醫學,藥理學,或生醫工程等相關學科的高階學位。大多具有紮實的研究和/或產業經驗,許多人在產業或大學任職,或在美國專利商標局擔任審查委員後加入Finnegan飛翰。

Everyone in this industry

Experience

Utility and design patent applications for brain machine interface company

Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.

In re Lumify

Successfully represented Bausch & Lomb and Eye Therapies in a Hatch-Waxman patent infringement litigation and parallel PTAB challenges concerning an ANDA for generic versions of over-the-counter Lumify® ocular drops. The cases settled favorably for our clients. 

3:21-cv-16766, D.N.J., Judges Kirsch, Singh
IPR2022-00146, PTAB, Judges Hulse, New, Pollock
IPR2024-00467, PTAB, Judges Flax, Pollock, Yang
IPR2022-00142, PTAB, Judges Flax, Hulse, New, Pollock

Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.
Representing Aerin Medical Inc. and The Foundry, LLC in a patent infringement case involving medical devices for treating nasal airways. Finnegan is also representing patent owners Aerin Medical Inc. and The Foundry, LLC in a series of inter partes review (IPR) challenges to the asserted patents.

1:23-cv-00756, D. Del., Judge Hall
IPR2024-00275, -00276, -00277, -00278, -00279, -00280, -00282, -00669, PTAB

Bay Materials, LLC v. 3M Company
Representing Bay Materials, LLC in district court patent litigation involving multilayer polymer sheet material used in clear dental aligners.

1:21-cv-01610, D. Del., Judges Andrews, Hall

Auris Health, Inc. v. Intuitive Surgical Operations

Represented Intuitive Surgical Operations on appeals from petitions for inter partes review (IPR) filed by Auris Health, Inc.

21-1473, -1732, -1733, Fed. Cir., Judges Prost, Dyk, Reyna
IPR2019-01173, -01533, -01547, PTAB, Judges Franklin, Hulse, Jenks, Worth, Yang

Medmix Switzerland AG v. Kettenbach GmbH and Co. KG et al.
Represented defendants Kettenbach GmbH and Co. KG, Kettenbach LP and Xinial Systems GmbH and Co. KG in a case brought against the Defendants’ dental products for patent and trademark infringement, as well as false advertising, in the United States. After Defendants obtained a final written decision from the U.S. Patent and Trademark Office (USPTO) finding all asserted patent claims in the case to be unpatentable, the parties settled.

2:21-cv-06613, E.D.N.Y., Judge Reyes

More

Insights

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: May 2026

June 30, 2026

Federal Circuit IP Blog

Federal Circuit Holds Defend Trade Secrets Act Claim Untimely Filed

June 22, 2026

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

More

Upcoming Events

Conference

31st Annual UMass Chan Research Retreat

October 14-15, 2026

Worcester

News

Commentary

Finnegan Taps Partner from Kirkland to Boost IP Team

June 12, 2026

Media Mention

Finnegan Hires Kirkland & Ellis Litigator for London Office

June 8, 2026

Commentary

Finnegan Hires Kirkland Partner as It Eyes UK Growth

June 8, 2026

Press Release

London-Based Life Sciences Litigator Jin Ooi Bolsters Finnegan’s Global IP Litigation Capabilities

June 8, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP